ACLX vs VRTX: Which Stock is Better?
Side-by-side comparison of Arcellx Inc and Vertex Pharmaceuticals Inc in 2026
ACLX
Arcellx Inc
$72.17
VRTX
Vertex Pharmaceuticals Inc
$442.08
Key Metrics Comparison
| Metric | ACLX | VRTX | Winner |
|---|---|---|---|
| Market Cap | $4.17B | $113.35B | VRTX |
| P/E Ratio | N/A | 31.15 | VRTX |
| EPS (TTM) | $N/A | $14.19 | VRTX |
| Revenue Growth | -0.8% | 0.1% | VRTX |
| Gross Margin | -368.5% | 52.7% | VRTX |
Analyze ACLX
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ACLX or VRTX a better investment?
Comparing ACLX and VRTX: Arcellx Inc has a market cap of $4.17B while Vertex Pharmaceuticals Inc has $113.35B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ACLX and VRTX?
ACLX (Arcellx Inc) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ACLX or VRTX?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ACLX or VRTX?
VRTX has higher revenue growth at 0.1% vs -0.8% for ACLX.
Which company is more profitable: ACLX or VRTX?
Vertex Pharmaceuticals Inc (VRTX) has higher gross margins at 52.7% compared to -368.5% for ACLX.
Which is the larger company: ACLX or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $113.35B compared to $4.17B for ACLX.
Should I buy ACLX or VRTX in 2026?
Both ACLX and VRTX have investment merit. ACLX trades at $72.17 while VRTX trades at $442.08. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ACLX and VRTX stock?
Key differences: Market Cap ($4.17B vs $113.35B), P/E Ratio (N/A vs 31.2x), Revenue Growth (-0.8% vs 0.1%), Gross Margin (-368.5% vs 52.7%).